Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice

Neuropharmacology

Volumn 35, Issue 2, 1996, Pages 153-158

  De Sarro, G ^a   Nava, F ^a   Aguglia, U ^b   De Sarro, A ^b  

^a School of Medicine   (Italy)

^b NONE

Author keywords

Anticonvulsants; Audiogenic seizures; Carbamazepine; DBA 2 mice; Epilepsy; Lamotrigine; Phenobarbital; Phenytoin; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; DRUG PROTEIN BINDING; FEMALE; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029986072     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00174-3     Document Type: Article

References (29)

1. Chapman A. G., Graham J. and Meldrum B. S. (1990) Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice. Eur. J. Pharmac. 178: 97-99.
2. Chapman A. G., Smith S. E. and Meldrum B. S. (1991a) The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466 in mice. Epilepsy Res. 9: 92-96.
3. Chapman A. G., Graham J. L., Patel S. and Meldrum B. S. (1991b) Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Epilepsia 32: 578-587.
4. Chapman A. G., Al-Zubaidy Z. and Meldrum B. S. (1993) Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur. J. Pharmac. 231: 301-304.
5. Cheung M., Kamp D. and Marris E. (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 13: 107-112.
6. De Sarro G. B. and De Sarro A. (1992) Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy prone rats. Eur. J. Pharmac. 215: 221-229.
7. De Sarro G. B. and De Sarro A. (1993) Anticonvulsant properties of non-competitive antagonists of NMDA receptor in genetically epilepsy prone rats. Comparison with CPPene. Neuropharmacology 32: 51-58.
8. De Sarro G. B., Croucher M. J., Meldrum B. S. (1984) Anticonvulsant actions of DS 103-282: pharmacological studies in rodents and the baboon, Papio papio. Neuropharmacology 23: 526-530, 1984.
9. Dunham N. W. and Miya T. S. (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46: 208-209.
10. Lamb R. J. and Miller A. A. (1985) Effect of lamotrigine, a novel anticonvulsant drug on visually evoked after-discharge in the conscious rat. Br. J. Pharmac. 86: 765.
11. Leach M. J., Marden C. M. and Miller A. A. (1986) Pharmacological studies of lamotrigine, a novel potential antiepileptic drug. Neurochemical studies on the mechanism of action. Epilepsia 27: 490-497.
12. Litchfield J. T. and Wilcoxon F. (1949) A simplified method of evaluating dose-effect experiments. J. Pharmac. Exp. Ther. 96: 99-113.
13. Löscher W. and Honack D. (1991) Anticonvulsant and behavioural effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmac. Exp. Ther. 256: 432-440.
14. Macdonald R. L. and Meldrum B. S. (1995) Principles of antiepileptic drug action. In: Antiepileptic Drugs (Levy R.H., Mattson R.H. and Meldrum B.S., Eds), 4th edn., pp. 61-77. Raven Press, New York.
15. McLean M. J. and MacDonald R. L. (1986) Sodium valproate, but not ethosuximide, produces use and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmac. Exp. Ther. 244: 789-795.
16. Meldrum B. S. (1984) Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia 25: S140-S149.
17. Miller A. A. and Wheatley P. L. (1985) Anticonvulsant action of lamotrigine, phenytoin and phenobarbitone on electrically-induced after discharge. Br. J. Pharmac. 85: 366.
18. Miller A. A., Sawyer D. A., Roth B., Peck A. W., Leach M. J., Wheatley P. L., Parson D. N. and Morgan R. J. I. (1986) Lamotrigine. In: New Anticonvulsant Drugs (Meldrum B. S. and Porter R. J., Eds), pp. 165-175. John Libbey, London.
19. Patel S., Chapman A. G., Graham J. L., Meldrum B. S. and Frey P. (1990) Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphono-propyl)piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphono-prop-2-enyl) piperazine-2-carboxylic acid (D-CPP-ene) in a rodent and primate model of reflex epilepsy. Epilepsy Res. 7: 3-10.
20. Rambeck B. and Wolf P. (1993) Lamotrigine. Clinical pharmacokinetics. Clin. Pharmacokinet. 25: 433-443.
21. Richens A. (1992) Lamotrigine. In: Recent Advances in Epilepsy (Pedley T.A. and Meldrum B.S., Eds), Vol. 5, pp. 197-210. Churchill Livingstone, New York.
22. Rogawski M. A. (1992) The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs 44: 279-292.
23. Smith S. E., Durmuller N. and Meldrum B. S. (1991) The non-N-methyl-D-aspartate receptor antagonists. GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmac. 201: 179-138.
24. Smith S. E., Al-Zubaidy Z., Chapman A. G. and Meldrum B. S. (1993) Excitatory amino acid antagonists, lamotrigine and BW 100C87 as anticonvulsants in the genetically epilepsy-prone rats. Epilepsy Res. 15: 101-111.
25. Srinivasan J. and Richens A. (1994) The safety and tolerability of lamotrigine. Rev. Contemp. Pharmacother. 5: 147-151.
26. Upton N. (1994) Mechanism of action of new antiepileptic drugs: rational design and serendipitous findings: TINS 15: 456-463.
27. Wolf P. (1992) Lamotrigine: preliminary clinical observatons on pharmacokinetics and interactions with traditional antiepileptic drugs. J. Epilepsy 5: 73-79.
28. Yuen A. W. C. (1995) Lamotrigine. Interaction with other drugs. In: Antiepileptic Drugs (Levy R. H., Mattson R. H. and Meldrum B. S., Eds), 4th ed., pp. 883-887. Raven Press, New York.
29. Yuen A. W. C., Land G., Weatherley B. C. and Peck A. W. (1992) Sodium valproate acutely inhibits lamotrigine metabolism. Br. J. Clin. Pharmac. 33: 511-513.